首页> 外文期刊>Nanotechnology >Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress
【24h】

Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress

机译:维生素E负载的白藜芦醇纳米乳剂,可通过降低氧化应激用于脑部靶向治疗帕金森氏病

获取原文
获取原文并翻译 | 示例
           

摘要

Resveratrol, a potent natural antioxidant, possesses a wide range of pharmacological activities, but its oral bioavailability is very low due to its extensive hepatic and presystemic metabolism. The aim of the present study was to formulate a kinetically stable nanoemulsion (o/w) using vitamin E:sefsol (1:1) as the oil phase, Tween 80 as the surfactant and Transcutol P as the co-surfactant for the better management of Parkinson's disease. The nanoemulsion was prepared by a spontaneous emulsification method, followed by high-pressure homogenization. Ternary phase diagrams were constructed to locate the area of nanoemulsion. The prepared formulations were studied for globule size, zeta potential, refractive index, viscosity, surface morphology and in vitro and ex vivo release. The homogenized formulation, which contained 150 mg ml(-1) of resveratrol, showed spherical globules with an average globule diameter of 102 +/- 1.46 nm, a least poly dispersity index of 0.158 +/- 0.02 and optimal zeta potential values of -35 +/- 0.02. The cumulative percentage drug release for the pre-homogenized resveratrol suspension, pre-homogenized nanoemulsion and post-homogenized nanoemulsion were 24.18 +/- 2.30%, 54.32 +/- 0.95% and 88.57 +/- 1.92%, respectively, after 24 h. The ex vivo release also showed the cumulative percentage drug release of 85.48 +/- 1.34% at 24 h. The antioxidant activity determined by using a DPPH assay showed high scavenging efficiency for the optimized formulation. Pharmacokinetic studies showed the higher concentration of the drug in the brain (brain/blood ratio: 2.86 +/- 0.70) following intranasal administration of the optimized nanoemulsion. Histopathological studies showed decreased degenerative changes in the resveratrol nanoemulsion administered groups. The levels of GSH and SOD were significantly higher, and the level of MDA was significantly lower in the resveratrol nanoemulsion treated group.
机译:白藜芦醇是一种有效的天然抗氧化剂,具有广泛的药理活性,但是由于其广泛的肝和全身代谢,其口服生物利用度很低。本研究的目的是使用维生素E:sefsol(1:1)作为油相,吐温80作为表面活性剂和Transcutol P作为辅助表面活性剂来配制动力学稳定的纳米乳液(o / w)帕金森氏病。通过自发乳化方法,然后高压均质化来制备纳米乳液。构造三元相图以定位纳米乳液的区域。研究了所制备的制剂的球大小,ζ电位,折射率,粘度,表面形态以及体外和离体释放。包含150 mg ml(-1)白藜芦醇的均质制剂显示球形小球,平均小球直径为102 +/- 1.46 nm,最小多分散指数为0.158 +/- 0.02,最佳zeta电位值为- 35 +/- 0.02。 24小时后,均质前白藜芦醇悬浮液,均质前纳米乳剂和均质后纳米乳剂的累积药物释放百分比分别为24.18 +/- 2.30%,54.32 +/- 0.95%和88.57 +/- 1.92%。离体释放还显示药物在24小时的累积释放百分比为85.48 +/- 1.34%。通过使用DPPH分析测定的抗氧化剂活性显示出优化配方的高清除效率。药代动力学研究表明,经鼻内施用优化的纳米乳剂后,大脑中药物的浓度较高(脑/血比:2.86 +/- 0.70)。组织病理学研究表明,白藜芦醇纳米乳给药组的变性变化减少。白藜芦醇纳米乳治疗组的GSH和SOD水平显着升高,MDA水平显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号